With great disappointment, we have cancelled the CCRM Australia Business of Regenerative Medicine Asia Pacific 2021 due to evolving COVID-related restrictions. We believe an in-person symposium brings more value to our participants which led to the cancellation of this year’s event.

Registrants will be contacted by Life Sciences Queensland for refunds. Please check your inbox for details.

Thank you to our sponsors and speakers who have committed to join the event. We are looking to host CCRM Australia Business of Regenerative Medicine Asia Pacific again next year. Follow us and subscribe to our newsletter to receive the announcement of next year’s event.


CCRM Australia in collaboration with Life Sciences Queensland present a two-day symposium to support and accelerate the translation and commercialisation of regenerative medicine. Join us for an opportunity to network and collaborate.

CCRM Australia is hosting a special event directed towards an Asia Pacific market and modelled on the successful Business of Regenerative Medicine (BRM) held annually in North America. BRM Asia will focus on themes to support and accelerate the translation and commercialisation of regenerative medicine. The symposium will provide biopharmas, biotechs, entrepreneurs, investors and early career researchers an opportunity to network and foster commercial collaboration.

For information about the speakers, themes, ticket pricing, catering and program, visit the event page on Life Sciences Queensland website:
https://www.lsq.com.au/tc-events/brmap21/

Read the press release here.

Travel grants are available for students and early career researchers (application closes 1 September 2021).